Sharda Cropchem Ltd management interview: Sharda Cropchem Q2: Revenue Up 13%, EBITDA Rises 18%; FY27 Growth Guidance Intact | Business News
ET Now, 2026-11-02. Video: https://www.youtube.com/watch?v=YcyXH-45OkM
- Margin guidance: Despite EBIT margins of 15.6% this quarter, management expects full-year EBITDA margins of 18% to 20%, citing the company’s seasonally stronger second half.
- Growth drivers: Revenue grew about 13%, with management confirming that both volume uptick and pricing contributed to growth.
- Europe outlook: Europe revenue declined 7%, but demand is picking up; weather effects remain, and management hopes conditions become more favorable.
- Business mix: The target mix remains 80% agro and 20% non-agro. Agrochemicals grew 5% and non-agro grew 68% in the second quarter; management expects non-agro to perform much better than the previous year.
- Investment and guidance: First-half CapEx was ₹419 crore, and full-year registration-related capital expenditure is expected to be ₹600 crore or little more. Management maintained FY27 revenue growth guidance of 10% to 15%, assuming conditions remain stable.